By matching the compound-related targets with the targets of NAFLD, 31 components and 70 potential targets against NAFLD for CRP were identified, suggesting that these targets might contribute to the hepatoprotection of CRP. This evidence concerns the gene CRP and metabolic dysfunction-associated steatotic liver disease.